In recent days, Regeneron Pharmaceuticals announced detailed positive Phase 2 trial results for two novel factor XI ...
Key Insights The projected fair value for Binastra Corporation Berhad is RM2.47 based on 2 Stage Free Cash Flow ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback